Myeloid Leukemia — Trials

Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

3,528 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 862
Recruiting: 498
Ph III recruiting: 47
Growth YoY: +4.1%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (617)

clinicaltrialsPublishedShowing 51–100 of 1,516 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03683433	Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation	recruiting	Phase 2	50	M.D. Anderson Cancer CenterOTHER	1	Sep 14, 2026	clinicaltrials
NCT04128501	Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting	active not recruiting	Phase 2	100	M.D. Anderson Cancer CenterOTHER	1	Sep 14, 2026	clinicaltrials